Keywords: ilex, ilx-651, starts, prostate, cancer, trial, oncology

ILEX' ILX-651 starts prostate cancer trial

Article | 28 June 2004

Print This

ILEX oncology has initiated a multicenter Phase II study of ILX-651 in patients with hormone-refractory prostate cancer whose disease has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in